Current Atherosclerosis Reports

, Volume 6, Issue 6, pp 447–452

Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?

  • William S. Harris
Article

Abstract

With each passing year, the evidence linking an increased risk for coronary heart disease (CHD) death with a chronic dietary deficiency in long-chain omega-3 (n-3) fatty acids (FAs) grows stronger. Recently, a federally mandated evidence-based review in the United States concluded that n-3 FAs, especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have clear cardioprotective effects, and national and international expert panels and health organizations have begun to call for increased EPA and DHA intakes. Consumption of between 450 and 1000 mg/d is recommended for those without and with known CHD, respectively. Based on animal and isolated cell studies, these FAs were presumed to have antiarrhythmic effects. The first direct evidence for this in humans was recently published, as were new data linking low n-3 FA intakes with risk for developing atrial fibrillation. The strength of the n-3 story has now led to a proposal that blood levels of EPA plus DHA be considered a new, modifiable, and clinically relevant risk factor for death from CHD.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Harris WS, Isley WL: Clinical trial evidence for the cardioprotective effects of omega-3 fatty acids. Curr Atheroscler Rep 2001, 3:174–179.PubMedGoogle Scholar
  2. 2.
    von Schacky C: The role of omega-3 fatty acids in cardiovascular disease. Curr Atheroscler Rep 2003, 5:139–145.Google Scholar
  3. 3.
    Nestel P: Effects of fish oils and fish on cardiovascular disease. Curr Atheroscler Rep 2001, 3:68–73.PubMedGoogle Scholar
  4. 4.
    Burr ML, Ashfield-Watt PA, Dunstan FD, et al.: Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003, 57:193–200.PubMedCrossRefGoogle Scholar
  5. 5.
    AHRQ report on omega-3 and cardiovascular disease. http://www.ahrq.gov/clinic/epcsums/o3cardsum.htm. Accessed on July 15, 2004.Google Scholar
  6. 6.
    AHRQ report on omega-3 and CHD risk factors. http://www.ahrq.gov/clinic/epcsums/o3cardrisksum.htm. Accessed on July 15, 2004.Google Scholar
  7. 7.
    AHRQ report on omega-3 and arrhythmias. http://www.ahrq.gov/clinic/tp/o3arrtp.htm. Accessed on July 15, 2004.Google Scholar
  8. 8.
    He K, Song Y, Daviglus ML, et al.: Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004, 109:2705–2711.PubMedCrossRefGoogle Scholar
  9. 9.
    Whelton SP, He J, Whelton PK, Muntner P: Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 2004, 93:1119–1123.PubMedCrossRefGoogle Scholar
  10. 10.
    Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747–2757.PubMedCrossRefGoogle Scholar
  11. 11.
    De Backer G, Ambrosioni E, Borch-Johnsen K, et al.: European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24:1601–1610.PubMedCrossRefGoogle Scholar
  12. 12.
    Van deWF, Ardissino D, Betriu A, et al.: Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003, 24:28–66.CrossRefGoogle Scholar
  13. 13.
    Priori SG, Aliot E, Blomstrom-Lundqvist C, et al.: Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2003, 24:13–15.PubMedCrossRefGoogle Scholar
  14. 14.
    Report from Scientific Advisory Committee on Nutrition in the UK. http://www.sacn.gov.uk/reports/. Accessed on July 15, 2004.Google Scholar
  15. 15.
    ISSFAL statement on EPA and DHA intake. http://www.issfal.org.uk/PUFA%20intakes.htm. Accessed on July 15, 2004.Google Scholar
  16. 16.
    Leaf A, Kang JX, Xiao YF, Billman GE: Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003, 107:2646–2652.PubMedCrossRefGoogle Scholar
  17. 17.
    Albert CM, Campos H, Stampfer MJ, et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113–1118.PubMedCrossRefGoogle Scholar
  18. 18.
    Siscovick DS, Raghunathan TE, King I, et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363–1367.PubMedCrossRefGoogle Scholar
  19. 19.
    Billman GE, Kang JX, Leaf A: Prevention of sudden cardiac death by dietary pure w-3 polyunsaturated fatty acids in dogs. Circulation 1999, 99:2452–2457.PubMedGoogle Scholar
  20. 20.
    Schrepf R, Limmert T, Claus WP, et al.: Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004, 363:1441–1442.PubMedCrossRefGoogle Scholar
  21. 21.
    Mozaffarian D, Lemaitre RN, Kuller LH, et al.: Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003, 107:1372–1377.PubMedCrossRefGoogle Scholar
  22. 22.
    Mozaffarian D, Psaty BM, Rimm EB, et al.: Fish intake and risk for incident atrial fibrillation. Circulation 2004, 110:368–373.PubMedCrossRefGoogle Scholar
  23. 23.
    Grandjean P, Weihe P, White RF, et al.: Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997, 19:417–428.PubMedCrossRefGoogle Scholar
  24. 24.
    Myers GJ, Davidson PW, Cox C, et al.: Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 2003, 361:1686–1692.PubMedCrossRefGoogle Scholar
  25. 25.
    US Food and Drug Administration Report on Fish and Mercury. http://www.fda.gov/bbs/topics/news/2004/NEW01038.html. Accessed July 15, 2004.Google Scholar
  26. 26.
    National Fisheries Institute listing of 10 most commonly-consumed fish in the US. http://www.nfi.org/?a=newsb=Top%20Ten%20SeafoodsPHPSESSID=11b6d3a82238b953ce39afaa7390c64b. Accessed July 15, 2004.Google Scholar
  27. 27.
    Guallar E, Sanz-Gallardo MI, van’t Veer P, et al.: Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002, 347:1747–1754.PubMedCrossRefGoogle Scholar
  28. 28.
    Salonen JT, Seppanen K, Nyyssonen K, et al.: Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 1995, 91:645–655.PubMedGoogle Scholar
  29. 29.
    Rissanen T, Voutilainen S, Nyyssönen K, et al.: Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events. The Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation 2000, 102:2677–2679.PubMedGoogle Scholar
  30. 30.
    Hallgren CG, Hallmans G, Jansson JH, et al.: Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr 2001, 86:397–404.PubMedGoogle Scholar
  31. 31.
    Yoshizawa K, Rimm EB, Morris JS, et al.: Mercury and the risk of coronary heart disease in men. N Engl J Med 2002, 347:1755–1760.PubMedCrossRefGoogle Scholar
  32. 32.
    Hites RA, Foran JA, Carpenter DO, et al.: Global assessment of organic contaminants in farmed salmon. Science 2004, 303:226–229.PubMedCrossRefGoogle Scholar
  33. 33.
    Sidhu KS: Health benefits and potential risks related to consumption of fish or fish oil. Regul Toxicol Pharmacol 2003, 38:336–344.PubMedCrossRefGoogle Scholar
  34. 34.
    Harris WS, von Schacky C: The Omega-3 Index: A new risk factor for sudden cardiac death? Prev Med 2004, 39:212–220.PubMedCrossRefGoogle Scholar
  35. 35.
    Harris WS, Sands SA, Windsor SL, et al.: Omega-3 fatty acids in cardiac biopsies from heart transplant patients: correlation with erythrocytes and response to supplementation. Circulation 2004, In press.Google Scholar
  36. 36.
    Dewailly E, Blanchet C, Lemieux S, et al.: n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 2001, 74:464–473.PubMedGoogle Scholar
  37. 37.
    Davidson M, Bulkow LR, Gellin BG: Cardiac mortality in Alaska’s indigenous and non-Native residents. Int J Epidemiol 1993, 22:62–71.PubMedCrossRefGoogle Scholar
  38. 38.
    Kromann N, Green A: Epidemiological studies in the Upernavik District, Greenland. Acta Med Scand 1980, 208:401–406.PubMedCrossRefGoogle Scholar
  39. 39.
    Burchfiel CM, Reed DM, Strong JP, et al.: Predictors of myocardial lesions in men with minimal coronary atherosclerosis at autopsy. The Honolulu Heart Program. Ann Epidemiol 1996, 6:137–146.PubMedCrossRefGoogle Scholar
  40. 40.
    Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985, 312:1205–1209.PubMedCrossRefGoogle Scholar
  41. 41.
    Harris WS: Fish oil supplementation: evidence for health benefits. Cleve Clin J Med 2004, 71:208.PubMedCrossRefGoogle Scholar
  42. 42.
    Burr ML, Fehily AM, Gilbert JF, et al.: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2:757–761.PubMedCrossRefGoogle Scholar
  43. 43.
    Marchioli R, Barzi F, Bomba E, et al.: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897–1903.PubMedCrossRefGoogle Scholar
  44. 44.
    Katan MB, Deslypere JP, van Birgelen AP, et al.: Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997, 38:2012–2022.PubMedGoogle Scholar
  45. 45.
    Marangoni F, Colombo C, Galli C: A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem 2004, 326:267–272.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • William S. Harris
    • 1
  1. 1.St. Luke’s Mid America Heart Institute and Department of MedicineUniversity of Missouri-Kansas City School of MedicineKansas CityUSA

Personalised recommendations